ATE293607T1 - Nitroimidazolderivate und diese enthaltende diagnostische bilderzeugungsmittel - Google Patents

Nitroimidazolderivate und diese enthaltende diagnostische bilderzeugungsmittel

Info

Publication number
ATE293607T1
ATE293607T1 AT00957119T AT00957119T ATE293607T1 AT E293607 T1 ATE293607 T1 AT E293607T1 AT 00957119 T AT00957119 T AT 00957119T AT 00957119 T AT00957119 T AT 00957119T AT E293607 T1 ATE293607 T1 AT E293607T1
Authority
AT
Austria
Prior art keywords
derivative
diagnostic imaging
imaging agents
agents containing
containing same
Prior art date
Application number
AT00957119T
Other languages
German (de)
English (en)
Inventor
Yoshihiro Takai
Tatsuo Ido
Michihiko Tsujitani
Original Assignee
Pola Chem Ind Inc
Yoshihiro Takai
Tatsuo Ido
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pola Chem Ind Inc, Yoshihiro Takai, Tatsuo Ido filed Critical Pola Chem Ind Inc
Application granted granted Critical
Publication of ATE293607T1 publication Critical patent/ATE293607T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/91Nitro radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/05Detecting, measuring or recording for diagnosis by means of electric currents or magnetic fields; Measuring using microwaves or radio waves
    • A61B5/055Detecting, measuring or recording for diagnosis by means of electric currents or magnetic fields; Measuring using microwaves or radio waves involving electronic [EMR] or nuclear [NMR] magnetic resonance, e.g. magnetic resonance imaging
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04Organic compounds
    • A61K51/041Heterocyclic compounds
    • A61K51/044Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K51/0453Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/05Isotopically modified compounds, e.g. labelled

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • High Energy & Nuclear Physics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Optics & Photonics (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Radiology & Medical Imaging (AREA)
  • Biophysics (AREA)
  • Pathology (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Surgery (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
  • Hydrogenated Pyridines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Pyrane Compounds (AREA)
AT00957119T 1999-09-13 2000-09-12 Nitroimidazolderivate und diese enthaltende diagnostische bilderzeugungsmittel ATE293607T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP25905799 1999-09-13
JP26031599 1999-09-14
PCT/JP2000/006226 WO2001019799A2 (en) 1999-09-13 2000-09-12 Nitroimidazole derivative and diagnostic imaging agent containing the same

Publications (1)

Publication Number Publication Date
ATE293607T1 true ATE293607T1 (de) 2005-05-15

Family

ID=26543940

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00957119T ATE293607T1 (de) 1999-09-13 2000-09-12 Nitroimidazolderivate und diese enthaltende diagnostische bilderzeugungsmittel

Country Status (10)

Country Link
US (1) US6743925B1 (https=)
EP (1) EP1218351B1 (https=)
JP (1) JP4116793B2 (https=)
KR (1) KR100708822B1 (https=)
AT (1) ATE293607T1 (https=)
AU (1) AU6878400A (https=)
CA (1) CA2384879C (https=)
DE (1) DE60019622T2 (https=)
ES (1) ES2237447T3 (https=)
WO (1) WO2001019799A2 (https=)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2841554B1 (fr) * 2002-07-01 2008-01-18 Commissariat Energie Atomique Composes de maleimides marques, leur procede de preparation et leur utilisation pour le marquage de macromolecules
US8257680B1 (en) 2004-02-24 2012-09-04 The General Hospital Corporation Catalytic radiofluorination
US9017724B2 (en) 2004-02-24 2015-04-28 The General Hospital Corporation Catalytic radiofluorination
WO2008090731A1 (ja) * 2007-01-23 2008-07-31 Pola Pharma Inc. 2-ニトロイミダゾール誘導体の製造法
CA2978149C (en) 2008-03-21 2019-02-12 The General Hospital Corporation Inositol derivatives for the detection and treatment of alzheimer's disease and related disorders
JP2012532879A (ja) * 2009-07-07 2012-12-20 ノームオキシーズ,インコーポレイテッド イノシトールトリピロリン酸を使用して多剤耐性を低減する方法
US20120219500A1 (en) 2009-10-26 2012-08-30 Fujifilm Ri Pharma Co., Ltd. Diagnostic agent for infectious diseases
NL1038473C2 (en) * 2010-12-24 2012-06-27 Centre Nat Rech Scient Cancer targeting using carbonic anhydrase isoform ix inhibitors.
ES2569196T3 (es) * 2011-09-22 2016-05-09 ihon Medi-Physics Co., Ltd. Compuesto marcado con flúor radiactivo
CA2959776A1 (en) * 2014-09-25 2016-03-31 Nihon Medi-Physics Co., Ltd. Renal imaging agent

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0819111B2 (ja) * 1987-10-22 1996-02-28 ポーラ化成工業株式会社 2―ニトロイミダゾール誘導体及びこれを有効成分とする放射線増感剤
EP0669913B1 (en) * 1992-11-19 2003-03-05 The Trustees Of The University Of Pennsylvania Detection of hypoxia
WO1995009844A1 (en) 1993-10-04 1995-04-13 Board Of Regents, The University Of Texas System Rapid synthesis and use of 18f-fluoromisonidazole and analogs

Also Published As

Publication number Publication date
DE60019622T2 (de) 2006-03-02
WO2001019799A3 (en) 2002-05-10
ES2237447T3 (es) 2005-08-01
WO2001019799A2 (en) 2001-03-22
JP4116793B2 (ja) 2008-07-09
AU6878400A (en) 2001-04-17
CA2384879C (en) 2010-11-30
EP1218351B1 (en) 2005-04-20
US6743925B1 (en) 2004-06-01
JP2003509413A (ja) 2003-03-11
DE60019622D1 (de) 2005-05-25
KR20020057955A (ko) 2002-07-12
KR100708822B1 (ko) 2007-04-17
CA2384879A1 (en) 2001-03-22
EP1218351A2 (en) 2002-07-03

Similar Documents

Publication Publication Date Title
NZ330973A (en) Azolobenzazepine derivatives as neurologically active agents
IL127965A0 (en) Pentafluorobenzenesulfonamide derivatives analogs thereof and pharmaceutical compositions containing the same
ES8303360A1 (es) Un procedimiento para la preparacion de derivados de 2,4-diaminoquinazolina.
ATE231143T1 (de) Triarylimidazole
EP1206937A4 (en) NICROIMIDAZOL PREPARATIONS FOR EXTERNAL USE FOR THE TREATMENT OF DERMATOSIS
PT650476E (pt) Agente vasodilatador periferico que contem derivados n-acilados de 4-amino-piperidina como ingredientes activos
TW200619199A (en) 3-carbamoyl-2-pyridone derivatives
NO162467C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive imidazo (1,5)-pyridiner og deres dihydro- og tetrahydroderivater.
TR199900618T2 (xx) Sib�tramin benzerlerinin diyabet geli�imini �nlemek �zere kullan�m�
DK177585A (da) Pyridazinoner
ATE353641T1 (de) Benzamide als kaliumkanal-inhibitoren
ATE293607T1 (de) Nitroimidazolderivate und diese enthaltende diagnostische bilderzeugungsmittel
DE60005502D1 (de) 4'-c-ethynyl-purin-nukleoside
EP1270017A4 (en) ACTIVE SUBSTANCES FOR THE DIAGNOSIS OF TISSUE-REPRODUCATIVE ACTIVITY OR FOR THE TREATMENT OF PROLIFERATIVE DISEASES
CA2336412A1 (en) Medicament for treatment of diabetes
NO941977D0 (no) Indolderivater, fremgangsmåte for fremstilling av disse, og medisinsk anvendelse derav
ES8500244A1 (es) "un procedimiento para preparar derivados de pirazinona"
GR3002832T3 (en) Flavone carboxylic acid derivatives
IT1255802B (it) Derivati imidazolici ad attivita' a ii antagonista
DK0538192T3 (da) Hidtil ukendte 17beta-substituerede aza-androstan-derivater
HRP20010885B1 (en) Ethanesulfonyl-piperidine derivatives
NO158622C (no) Analogifremgangsmaate for fremstilling av benzosyrederivater med antimikrobiell aktivitet.
CA2231118A1 (en) Pharmaceutical preparation containing nimesulide for topical use
WO1999023092A3 (en) 3-aminoalkylamino-2h-1,4-benzoxa(thia-)zines and pharmaceutical compositions containing them
EP0995437A4 (en) 2,3-DIHYDROBENZOFURAN DERIVATIVES

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1218351

Country of ref document: EP

EEIH Change in the person of patent owner